RaySearch Laboratories AB (publ)
STO:RAY B
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
84.8378
216
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ)
Total Receivables
RaySearch Laboratories AB (publ)
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
Total Receivables
kr398.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
ContextVision AB
OSE:CONTX
|
Total Receivables
kr28.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
M
|
Mentice AB
STO:MNTC
|
Total Receivables
kr90.4m
|
CAGR 3-Years
40%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
O
|
Ortivus AB
STO:ORTI B
|
Total Receivables
kr17m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Sectra AB
STO:SECT B
|
Total Receivables
kr1.6B
|
CAGR 3-Years
36%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kontigo Care AB
STO:KONT
|
Total Receivables
kr3.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
RaySearch Laboratories AB (publ)
Glance View
RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
See Also
What is RaySearch Laboratories AB (publ)'s Total Receivables?
Total Receivables
398.3m
SEK
Based on the financial report for Dec 31, 2023, RaySearch Laboratories AB (publ)'s Total Receivables amounts to 398.3m SEK.
What is RaySearch Laboratories AB (publ)'s Total Receivables growth rate?
Total Receivables CAGR 5Y
-3%
Over the last year, the Total Receivables growth was 0%. The average annual Total Receivables growth rates for RaySearch Laboratories AB (publ) have been 3% over the past three years , -3% over the past five years .
You don't have any saved screeners yet
